ReviewLiver international : official journal of the International Association for the Study of the Liver2026
Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.
Review in Liver international : official journal of the International Association for the Study of the Liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.Liver international : official journal of the International Association for the Study of the Liver · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol-related hepatocellular carcinoma is an increasingly prevalent consequence of alcohol use and the often-silent progression of alcohol-related liver disease. A substantial proportion of patients with alcohol-related hepatocellular carcinoma are diagnosed at an advanced stage, frequently because underlying liver disease has not been previously identified and surveillance has not been implemented. This review summarizes recent epidemiological trends and clinical features of alcohol-related hepatocellular carcinoma, with a particular focus on the high proportion of undiagnosed cirrhosis and the challenges posed by alcohol use disorder, comorbidities and socioeconomic vulnerability. Strengthening collaboration between hepatology and addiction medicine, alongside population-level strategies to reduce alcohol use, will be essential to enhance surveillance uptake and ultimately improve outcomes in alcohol-related hepatocellular carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.